Headquartered in Riom (France), Verdot Ips² has established itself, over its 20-year history, as a leading, independent biomanufacturing tools company. Specialized in the design, manufacturing and installation of custom-made industrial purification equipment, its target end markets are the Biotech, Pharmaceutical, Veterinary and Food industries. The company is focused on Low-Pressure Liquid Chromatography (LPLC) devices that play a key role in the manufacturing and development of complex biologic molecules including monoclonal antibodies, vaccines, and gene therapies.

Backed by strong, in-house scientific, technological and regulatory know-how, the company took a decisive, strategic turn several years ago when it chose to develop and market innovative, single-use chromatography equipment. Thanks to a solid network of clients made up of the largest pharmaceutical and biotechnology groups, Verdot Ips² is well established internationally, particularly in the United States, where it generates almost half of its revenue.